Cargando…
A dePEGylated Lipopeptide-Based Pan-Coronavirus Fusion Inhibitor Exhibits Potent and Broad-Spectrum Anti-HIV-1 Activity without Eliciting Anti-PEG Antibodies
We previously identified a lipopeptide, EK1C4, by linking cholesterol to EK1, a pan-CoV fusion inhibitory peptide via a polyethylene glycol (PEG) linker, which showed potent pan-CoV fusion inhibitory activity. However, PEG can elicit antibodies to PEG in vivo, which will attenuate its antiviral acti...
Autores principales: | Xu, Ling, Wang, Chao, Xu, Wei, Xing, Lixiao, Zhou, Jie, Pu, Jing, Fu, Mingming, Lu, Lu, Jiang, Shibo, Wang, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253554/ https://www.ncbi.nlm.nih.gov/pubmed/37298729 http://dx.doi.org/10.3390/ijms24119779 |
Ejemplares similares
-
On-demand PEGylation and dePEGylation of PLA-based nanocarriers via amphiphilic mPEG-TK-Ce6 for nanoenabled cancer chemotherapy
por: Zhu, Yueqiang, et al.
Publicado: (2019) -
Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection
por: Lan, Qiaoshuai, et al.
Publicado: (2021) -
Drug Delivery Systems with a “Tumor-Triggered” Targeting or Intracellular Drug Release Property Based on DePEGylation
por: Ren, Zhe, et al.
Publicado: (2022) -
A broad-spectrum bactericidal lipopeptide with anti-biofilm properties
por: Meir, Ohad, et al.
Publicado: (2017) -
The Antihistamine Drugs Carbinoxamine Maleate and Chlorpheniramine Maleate Exhibit Potent Antiviral Activity Against a Broad Spectrum of Influenza Viruses
por: Xu, Wei, et al.
Publicado: (2018)